Cross-protection by MF59™-adjuvanted influenza vaccine: Neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses

Detection of Antibody to Avian Influenza A (H5N1) Virus in Human Serum by Using a Combination of Serologic Assays

Thomas Rowe, Robert A. Abernathy, Jean Hu‐Primmer et al. · Journal of Clinical Microbiology · 1999 · 814 citations · Full text

Veterinary Medicine, Infectious Diseases, Diagnostic Microbiology +13

Cross‐Reactivity to Highly Pathogenic Avian Influenza H5N1 Viruses after Vaccination with Nonadjuvanted and MF59‐Adjuvanted Influenza A/Duck/Singapore/97 (H5N3) Vaccine: A Potential Priming Strategy

Iain Stephenson, Roberto Bugarini, Karl G. Nicholson et al. · The Journal of Infectious Diseases · 2005 · 285 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly

J.C. de Jong, W.E.P. Beyer, A.M. Palache et al. · Journal of Medical Virology · 2000 · 231 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly

S. De Donato, Dan M. Granoff, M Minutello et al. · Vaccine · 1999 · 185 citations

Veterinary Medicine, Immunology, Infectious Diseases +12

Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?

W.E.P. Beyer, A.M. Palache, Guido Lüchters et al. · Virus Research · 2004 · 173 citations

Veterinary Medicine, Immunology, Infectious Diseases +16